Integrated Wealth Concepts LLC Purchases 5,701 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

Integrated Wealth Concepts LLC lifted its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 26.6% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 27,125 shares of the exchange traded fund’s stock after buying an additional 5,701 shares during the quarter. Integrated Wealth Concepts LLC’s holdings in SPDR S&P Biotech ETF were worth $2,443,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also modified their holdings of the company. Addison Advisors LLC boosted its holdings in SPDR S&P Biotech ETF by 27.4% during the fourth quarter. Addison Advisors LLC now owns 535 shares of the exchange traded fund’s stock valued at $48,000 after acquiring an additional 115 shares during the period. Invst LLC lifted its stake in shares of SPDR S&P Biotech ETF by 6.0% in the third quarter. Invst LLC now owns 2,807 shares of the exchange traded fund’s stock valued at $277,000 after buying an additional 160 shares during the period. Beech Hill Advisors Inc. grew its position in SPDR S&P Biotech ETF by 2.5% during the fourth quarter. Beech Hill Advisors Inc. now owns 6,655 shares of the exchange traded fund’s stock worth $599,000 after buying an additional 162 shares in the last quarter. Wealth Alliance increased its stake in SPDR S&P Biotech ETF by 4.4% during the fourth quarter. Wealth Alliance now owns 4,083 shares of the exchange traded fund’s stock valued at $368,000 after acquiring an additional 173 shares during the period. Finally, CX Institutional raised its holdings in SPDR S&P Biotech ETF by 1.6% in the 4th quarter. CX Institutional now owns 12,196 shares of the exchange traded fund’s stock valued at $1,098,000 after acquiring an additional 196 shares in the last quarter.

SPDR S&P Biotech ETF Trading Down 0.8 %

Shares of NYSEARCA:XBI opened at $80.25 on Monday. The firm has a market capitalization of $5.10 billion, a PE ratio of 11.47 and a beta of 1.00. SPDR S&P Biotech ETF has a 1-year low of $66.66 and a 1-year high of $105.47. The business’s 50 day moving average is $82.53 and its 200-day moving average is $90.44.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.